Bioanalysis

Article	Citations
Meet the Editorial Board – An Interview with Min Meng and Transitions from Small Regional Labs to Global CRO	46
Biomonitoring of Arsenic, Lead, Manganese and Mercury in Hair from a Presumably Exposed Uruguayan Child Population	34
Volumetric Absorptive Microsampling as An Effective Microsampling Technique for LC–MS/MS Bioanalysis of Biomarkers in Drug Discovery	30
Patient centric blood sampling and analysis for diagnostics and laboratory medicine	28
MS-DIAL pre-processing for mining schistosomiasis metabolites in urine samples from the Okavango Delta of Botswana from a GC-MS dataset	26
Adopting ambient ionization mass spectrometry into bioanalytical laboratories	23
The complexities of oligonucleotide therapeutics: analytical challenges and opportunities within early drug discovery	22
Bioanalysis by LC-MS/MS and Preclinical Pharmacokinetic Interaction Study of Ribociclib and Oleanolic Acid	18
A fully automated novel solid-phase extraction method for siRNA drug extraction and quantitation across multiple tissues using LC-MS	16
A validated UHPLC-MS/MS method for determination of BPI-43487 and its metabolite BPI-43739 in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumors	16
Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox	16
Signal-to-noise Ratio to Assess Magnitude, Kinetics and Impact on Pharmacokinetics of the Immune Response to an Adalimumab Biosimilar	16
Biomarker Context-Of-Use: How Organizational Design Can Impact the Implementation of the Appropriate Biomarker Assay Strategy	15
Patient-centric clinical trials: collaboration and innovation in bioanalytical and clinical operations	15
2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot &a	15
Uncovering the Green Frontier: Harnessing Deep Eutectic Solvents for Sustainable Bioanalysis	15
Mitigating ADA matrix interferences: semiquantitative double immunoprecipitation for anti-bevacizumab antibody in plasma	14
Iron oxide nanozymes as versatile analytical tools: an overview of their application as detection technique	14
Strategy and Validation of a Nonclinical Generic Plug-and-Play Antidrug Antibody Method for Human Monoclonal Antibody Biotherapeutics	14
Refined ADA testing strategy to overcome sRANKL interference in denosumab/FKS518 immunogenicity assessment	13
A clever evaluation of the antidiabetic medications linagliptin and empagliflozin in bulk and spiked urine samples	12
Recent advances in gold nanoparticle-based colorimetric aptasensors for chemical and biological analyses	12
Whole blood stability in bioanalytical method validation: updated recommendations from the European Bioanalysis Forum	12
Selective IgM digestion improves anti-AAV IgG detection in the immune complex assay format	12
HPPA as assay substrate for improved capturing of sample variability during cut point analyses in immunogenicity testing	12

Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients	11
The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC–MS/MS	11
Bioanalysis Rising Star Award 2024: interviews with the finalists	11
An LC–MS/MS Method for Simultaneous Determination of LB-100 and Its Active Metabolite, Endothall, in Human Plasma	11
Accurate quantification of anti-drug antibodies against each unique Fab of a bispecific antibody using an ECL bridging assay	11
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Anahita Keyhani	11
Bioanalysis of free antisense oligonucleotide payload from antibody–oligonucleotide conjugate by hybridization LC-MS/MS	11
Perspectives on a Flexible Strategy for the Management of Nonregulated Bioanalysis	10
Development of a fit-for-purpose semi-homogeneous competitive ELISA for total PEG quantitation in a PEGylated molecule	10
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for Biomarkers	10
A comparison of branched DNA and reverse transcriptase quantitative polymerase chain reaction methodologies for quantitation of lipid nanoparticle encapsulated mRNA	10
Comparison of Assay Formats Used for the Detection of Pre-Existing Anti-Drug Antibodies Against Monoclonal Antibodies	10
A novel LC-MS/MS method for simultaneous estimation of chlordiazepoxide and clidinium in human plasma and its application to pharmacokinetic assessment	10
Validation of an LC–MS/MS method for the determination of sotorasib, a KRAS G12C inhibitor, in human plasma	10
Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency	10
Ligand-binding assays vs chromatographic platforms for oligonucleotide quantification	10
Significant matrix effect in fludarabine quantification in plasma: implications for CAR-T cell therapy monitoring	10
Accelerating the discovery of MET inhibitors powered by high-throughput hit identification	10
Quantification and pharmacokinetic assessment of SB225002 in mouse: a selective non-peptide CXCR2 antagonist	10
Correction	10
Western Blotting: Evolution of an Old Analytical Method To a New Quantitative Tool for Biomarker Measurements	9
Correction	9
Highlights of the 13th Japan Bioanalysis Forum Symposium	9
Considerations in Designing and Implementing a Bioanalytical Contract Research Organization Key Performance Indicator System	9
Method development for the quantification of lead levels in whole blood sampled on Mitra ® with VAMS ® tips by inductively coupled	9
Highlights of the 15th Japan Bioanalysis Forum Symposium	9
Inception and Development of a LC–MS/MS Assay for the Multiplexed Quantitation of Nine Human Drug Transporter Biomarkers	9
Augmenting immunogenicity workflows with AI and real-world evidence: failure points, tools, and a closed-loop operational blueprint	8
Nucleic acid nanorobot assay for accurate and simplified ASO quantification in mouse plasma	8
An interview with Bioanalysis : speaking with the 2025 international reid bioanalytical forum bursary award winners	8
Validation of UV–Vis spectrophotometric colorimetric methods for Rifampicin quantification in PBS & biological matrices	8
Development and Validation of qPCR Methods for Nucleic Acid Biomarkers as a Drug Development Tool: Points to Consider	8
A Sensitive, Robust and High-Throughput Isotope Dilution LC–MS/MS Method for Quantifying Three Folate Forms in Serum	8
Novel Isoelectric Target Depletion (ITaD) Protocol Reduces the Need for Specific Reagents for Immunogenicity Testing	8
Determination of meropenem in capillary plasma microsamples using LC–MS/MS	8
Critical Reagent Inventory Management System and Web Portal Specifically Optimized for Supporting External Clients	8
High Ionic Strength Dissociation Assay Reduces Dimeric Target Interference in Immunogenicity Testing	8
Determination of Amphetamines, Opioids, Cocaine Metabolites and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Using Biocompatible Solid-Phase Microextraction and Ultra-Performance LC–MS/MS	7
Upfront Acid Treatment with Low Final pH: The Development and Testing of a Novel Method to Improve Drug Tolerance in Antidrug Antibody Assays	7
Perspective on High-Throughput Bioanalysis to Support In Vitro Assays in Early Drug Discovery	7
Beyond contracts: principles for Pharma–CRO collaboration from the European Bioanalysis Forum	7
Affinity-maturation engineering via phage display to optimize anti-idiotype antibodies for neutralizing antibody assays	7
Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations	7
Effect of Chronopharmacology and Food on in Vivo Pharmacokinetic Profile of Mavacamten	7
Molecularly Imprinted Electrochemical Biosensor for Thrombin Detection by Comparing Different Monomers	7
Development of an LC-MS/MS assay to analyze a lipid-conjugated siRNA by solid phase extraction (SPE) in mouse plasma and tissue using a stable isotope labeled internal standard (SILIS)	7
DoE-assisted HPLC method development and validation of enzalutamide and repaglinide in rat plasma	7
Determination of aloesone in rat plasma by LC–MS/MS spectrometry and its application in a pharmacokinetic study	7
HPLC Method for Simultaneous Estimation of Paclitaxel and Baicalein: Pharmaceutical and Pharmacokinetic Applications	6
Development of LC–MS/MS Method for Cyanoenone Triterpenoid Determination to Support CNS Tissue Distribution Study	6

Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum	6
Quantitation of BCAA and BCKA in plasma and patient-centric dried blood microsamples in a clinical setting	6
Greener Bioanalytical Sample Preparation. What is Next?	6
Comparison of multiple bioanalytical assay platforms for the quantitation of siRNA therapeutics	6
Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats	6
Role of miRNA-21 in cancer and its application in electrochemical bioanalysis	6
Ocular Bioanalysis of Moxifloxacin and Ketorolac Tromethamine in Rabbit Lacrimal Matrix Using Liquid Chromatography–Tandem Mass Spectrometry	6
Development and validation of a bioanalytical method to quantify povorcitinib in human skin with clinical application	6
An Eco-Friendly Ultra-Performance Liquid Chromatography–Mass Spectrometry Method for Quantification of Rivaroxaban and Ticagrelor in Rat Plasma: Grapefruit Interactions	6
Rethinking validation paradigms for qPCR and dPCR assays in bioanalysis	6
Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis	6
Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates	6
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC–MS/MS	6
Revolutionizing depression diagnosis: earwax analysis for cortisol and beyond	6
Development and validation of bioanalytical methods to support clinical study of disitamab vedotin	6
Comparison of Requirements for Clinical Study of SARS-CoV-2 Antigen Test Kits in China, the USA and Europe	6
Fabry Disease Biomarkers in Patients Switched From Enzyme-Replacement Therapy to Migalastat Oral Chaperone Therapy	5
Single-Analyte Biomarker Assays for Pharmacodynamic or Safety Assessment During Biotherapeutic Development	5
LC–MS Bioanalysis of Protein Biomarkers and Protein Therapeutics in Formalin-Fixed Paraffin-Embedded Tissue Specimens	5
Development and validation of highly sensitive ligand binding assay to measure soluble DLL3 concentration in human serum	5
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management	5
A comprehensive LC–MS based study of factors influencing biotinylation of critical reagents	5
Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats	5
Validation and Application of Hybridization Liquid Chromatography-Tandem Mass Spectrometry Methods for Quantitative Bioanalysis of Antisense Oligonucleotides	5
LC-MS/MS method for co-estimation of doxorubicin and piperine: formulation development and pharmacokinetic studies	5
Development and validation of an LC–MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma	5
LC–MS/MS Methods for Direct Measurement of Sepiapterin and Tetrahydrobiopterin in Human Plasma and Clinical Applications	5
Assessing linearity of vaccine immunogenicity assays: application and link with clinical endpoints	5
Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies	5
Characterization of Murine Lymphocyte Activation and Exhaustion Markers by a 14-Color Flow Cytometry Panel	5
A Validated Method for the Determination of Hematocrit in Dried Blood Spots Using Image Analysis	5
Insights and Future Trends in Bioanalysis: An Interview With Jing Tu	5
Expanding Assay Range to Accommodate a Monoclonal Antibody Therapeutic Quantification in Blood and Cerebrospinal Fluid	5
Pitfalls in bioanalytical work with a Japanese CRO or sponsor: from a project risk management perspective	5
A Biomarker Assay Validation Approach Tailored to The Context of Use and Bioanalytical Platform	5
The acute oral toxicity and pharmacokinetic determination of a novel chloroquinoline hybrid molecule by LC-MS/MS	5
When is a sample a urine sample? Markers for urine sample authenticity assessment in sports drug testing	5
Detection of Streptococcus anginosus in fecal samples using PCR-CRISPR /Cas12a system	5
A Smartphone Digital Image Colorimetric Method Based on Nanoparticles for Determination of Lamotrigine	5
Bioanalysis of tucatinib and metabolite, and a five-way cross-validation to support clinical pharmacokinetic analysis	5
Harmonization of Vaccine Ligand Binding Assays Validation	5
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity control	5
High-resolution mass spectrometry for glycoproteomics	5
Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling	5
Bioanalytical tandem mass spectrometry method for cinacalcet in human plasma: green assessment with advanced metrics	5
Artificial intelligence and blockchain in clinical trials: enhancing data governance efficiency, integrity, and transparency	4
Thyroxine Biosensors: A Review on Progress and Challenges	4
Utilizing Droplet Digital Polymerase Chain Reaction for siRNA Quantitation in Rodent Plasma and Tissue Via Stem-Loop Reverse Transcription	4
Method development and validation for simultaneous analysis of four bile acids as CYP3A drug–drug interaction biomarkers	4
Green HPLC method for determination of paracetamol and ibuprofen in human plasma: applications to pharmacokinetics	4
Development and Validation of Reversed-Phase-HPLC Method for Simultaneous Quantification of Fulvestrant and Disulfiram in Liposomes	4
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?	4
Low-volume collection devices for longitudinal biomarker monitoring in patient-centric sampling settings	4
Volumetric absorptive microsampling–LC–MS/MS assays for quantitation of giredestrant in dried human whole blood	4
Simultaneous estimation of donepezil and quercetin using ultra high performance liquid chromatography: pharmaceutical and pharmacokinetic applications in Alzheimer’s disease	4
Development and validation of an antidrug antibody assay for TRK-950 using Melon™ gel and SPEAD pretreatment	4
BiSim Tool: a binding simulation tool to aid and simplify ligand-binding assay design and development	4
A Validated Capillary Microsampling Liquid Chromatography–Tandem Mass Spectrometry Method for Quantification of Antisense Oligonucleotides in Mouse Serum	4
Streamlined neutralizing antibody assay development: overcoming serum interference, utilization of DOE and automation	4
Integrating metering capabilities to increase the utility of self-collected, dried samples	4
Enantioselective electrochemical detection of a L-and D-serine at polyvinylpyrrolidone-modified platinum electrode	4
An update on the European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: biomarker and anti-drug-antibody assays	4
Harmonizing immunogenicity for AAV and LNP/mRNA modalities: best-practice panels for binding, neutralizing, and cellular assays with pre-existing immunity controls	4
Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serum	4
Bioanalysis Rising Star Award 2023: announcing our finalists	4
Validated HPLC Method for Ceftriaxone from Dried Blood Spots for Pharmacokinetic Studies and Therapeutic Drug Monitoring in Neonatal Population	4
Quantification of MDR-TB drug JBD0131 and its metabolite in plasma via UPLC-MS/MS: application in first-in-human study	4
Mitigation of pre-existing immunogenicity in ADA method development	4
Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum	4
Mass spectrometry for clinical bioanalysis without chromatographic separation: bioequivalence for bupropion and its metabolites	4
Moving into the cloud: a summary from a European Bioanalysis forum workshop on introducing cloud applications in bioanalytical laboratories	4
Research progress of N -nitrosamine detection methods: a review	4
Measuring HSD17β13 protein turnover in mouse liver with D 2 O metabolic labeling and hybrid LC-MS	4
Multi-residue analysis method based on QuEChERS followed by ultra-high performance liquid chromatography coupled with diode-array detector for pesticides in human serum and breast milk	4
Thalidomide Measurement in Plasma and Dried Plasma Spot by SPE Combined with UHPLC-MS/MS for Therapeutic Drug Monitoring	3
Covalent organic frameworks: spotlight on applications in the pharmaceutical arena	3
Two decades of immunocapture liquid chromatography tandem mass spectrometry for pharmaceutical discovery and development: reflections and recommendations for optimal deployment	3
Single-Day Protein LC–MS Bioanalysis: Can Next-Generation Trypsins Cut It?	3
Singlicate analysis in ADA assays: comparing assay performance in duplicate and singlicate formats	3
A new sensitive derivatization assay of PrC-210 in plasma and tissues using liquid chromatography coupled with tandem mass spectrometry	3

2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments;	3
A High-Speed Microscopy System Based on Deep Learning to Detect Yeast-Like Fungi Cells in Blood	3
High-sensitivity Quantification of Antisense Oligonucleotides for Pharmacokinetic Characterization	3
Preclinical Pharmacokinetics of 4-Hydroxy Isoleucine Using Lc–Ms/Ms: A Potential Polycystic Ovary Syndrome Phytopharmaceutical Therapeutics	3
Feasibility of using PALSAR technology as a signal amplifier for antibody bridging assay	3
Green Bioanalysis: An Innovative and Eco-Friendly Approach for Analyzing Drugs in Biological Matrices	3
Bioanalysis of INCB000928 in hemodialysate: prevention of nonspecific binding and validation of surrogate matrices	3
Quantitative Chromatographic Method Development for Residual Lidocaine in Topical Systems and Biological Samples	3
Blood Cell Quantification on Dry Blood Samples: Toward Patient-Centric Complete Blood Counts	3
Pertinence of microsampling in various nonclinical and clinical studies: the ICH perspective	3
Correction	3
Pharmacokinetics and Toxicity Considerations for Antibody–drug Conjugates: An Overview	3
Advances in green sample preparation methods for bioanalytical laboratories focusing on drug analysis	3
Surrogate Peptide Selection and Internal Standardization for Accurate Quantification of Endogenous Proteins	3
Quantifying skin permeation of a novel metformin lotion using modified hydrophilic interaction liquid chromatography	3
Impact of positive control binding properties on anti-drug antibody assay performance	3
Lessons Learned from Regulatory Submissions Involving Endogenous Therapeutic Analyte Bioanalysis	3
Stability of Nonsteroidal Anti-Inflammatory Drugs in Urine and Solution: Effects of Degradation on Analytical Assessment	3
High-Throughput MS for Intact Protein Analysis	3
16 th GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytica	3
Effect of delayed blood centrifugation on cytokine quantitation in serum and plasma	3
Objective criteria for statistical assessments of cross validation of bioanalytical methods	3
Free serum concentrations of antibiotics determined by ultrafiltration: extensive evaluation of experimental variables	3
Development of a UPLC-MS/MS method for simultaneous quantification of 7 bile acids in feces: application to UC mice	3
LC–MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies	3
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline	3
Simultaneous quantitation of tigecycline, meropenem, polymyxin B in plasma, and protein-binding analysis in HSCT patients	3
Meet the Editorial Board: An Introduction to and Insights from Fumin Li	3
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bio	3
Flow cytometry vs conventional methods for the evaluation of anti-PF4/heparin antibodies: a single center study	3
Accelerating isotope dilution LC-MS-based desmosine quantification for estimating elastin turnover	3
Comparison of Pharmacokinetic Profiles in Hypoalbuminemia and Healthy Rats After Parecoxib Sodium Injection by LC–MS/MS	3
Analytical Considerations to Support Expeditious Formulation Development of Vaccines	3
Unique challenges required reassessment and alterations to critical reagents to rescue a neutralizing antibody assay	3
2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolonga	3
Evaluation of hemaPEN ® sampling device for measurement of cocaine and metabolites in capillary blood by LC-MS/MS	3
Evaluation of the light-initiated chemiluminescence assay for quantification of Humulus scandens pollen - specific IgE	2
From 3-Tier to adaptive immunogenicity testing strategies: recommendations from the European Bioanalysis Forum	2
Using Innovative Tools for In Vitro Absorption, Distribution, Metabolism and Excretion Studies to Efficiently and Effectively Support Drug Development	2
Mass spectrometry approaches for monitoring therapeutic response in major depressive disorder	2
Integrity and Efficiency: AbbVie’s Journey of Building an Integrated Nonregulated Bioanalytical Laboratory	2
Challenges and Current Advances in the Methodology of Thyroglobulin Measurements	2
Bioanalysis of Six Antibiotics from Volumetric Microsamples: A New Tool for Precision Dosing in Critically ill Children	2
An LC-MS/MS method for the determination of Lifitegrast in human plasma and tear and its application in the pharmacokinetic study	2
Tuberculosis diagnosis versus GeneXpert ® MTB/RIF formats	2
Bioanalytical methods in doping controls: a review	2
WRIB Poster Awards Winners 2024	2
LC–MS/MS Method for the Quantitation of OCT1 Biomarker Isobutyrylcarnitine in Human Plasma with Clinical Sample Analysis	2
Development and validation of an LC-MS/MS method for the quantification of novel therapeutic TT-478, a selective adenosine receptor 2B antagonist, for a phase I/II clinical trial	2
LC–MS/MS Assay of Fluoropezil and Its Two Major Metabolites in Human Plasma: An Application to Pharmacokinetic Studies	2
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Shefali R Patel	2
Mitigating target interference challenges in bridging immunogenicity assay to detect anti-tocilizumab antibodies	2
Analysis of Free Concentrations of Lamotrigine and Active Oxcarbazepine Metabolite in Clinical Patients by Hollow-Fiber Centrifugal Ultrafiltration	2
Observations from a decade of oligonucleotide bioanalysis by LC-MS	2
Development of production methodologies for scFv-Fc conjugated critical reagents to support CAR-T clinical programs	2
Conference report for the 10th China Bioanalysis Forum annual meeting	2
Recent advances in the identification and quantification of xylazine and medetomidine in biological specimens	2
Navigating IVDR challenges for pharmacokinetic, anti-drug antibodies, and biomarker assays in early clinical research: a recommendation from the European Bioanalysis Forum	2
Automation of tacrolimus measurement on volumetric absorptive microsampling devices by tandem mass spectrometry	2
The fusion of microfluidics and artificial intelligence: a novel alliance for medical advancements	2
Analysis of Tigecycline in the Cerebrospinal Fluid and Serum of Patients with Acinetobacter Baumannii Central Nervous System Infection	2
A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkers	2
European Bioanalysis Forum recommendation on embracing a context-of-use-driven scientific validation for chromatographic assays in the light of ICH M10	2
Liquid chromatographic methods in the determination of inosine monophosphate dehydrogenase enzyme activity: a review	2
A simple and highly sensitive LC-MS/MS bioanalytical method for phosphorodiamidate morpholino oligonucleotides in plasma	2
Evolving bioanalytical strategies in the wake of pioneering biotherapeutics	2
Immunocapture LC–MS Methods for Pharmacokinetics of Large Molecule Drugs	2
Ultra-high throughput mass spectrometry with ultra high-speed separations: differential mobility spectrometry–acoustic ejection mass spectrometry (DAEMS)	2
An LC–MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma	2
2025 White Paper on Recent Issues in Bioanalysis: What is the Future of Bioanalytical LIMS? AI/ML Integration in Bioanalysis; Tear Sample Collection; Radiolabeled Mass Balance Studies; Chiral Assays;	2
Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffs	2
Considerations for Drug Development Biomarker Assays in the Clinical Laboratory	2
Pharmacokinetic study of isavuconazonium in human plasma measured by HPLC-MS/MS and its use in healthy Chinese subjects	2
A rapid and sensitive UHPLC-MS/MS method for epalrestat detection in micro-volumes of human plasma for the first time	2
Patient-centric microsampling for abrocitinib pharmacokinetics: multiple-analytes assay bridging using Tasso device	2
Highlights of the 14th Japan Bioanalysis Forum Symposium	2
Implementation of the fully automated diagnostic immunoanalyzer cobas e411 in the bioanalytical laboratory - Lessons learnt	2
Development and validation of an LC–MS/MS method to quantify kynurenic acid in human plasma	2
Immunocapture mass spectrometry: macroscopic history, recent trends and future prospects	2
Determination of drugs of abuse and metabolites in plasma microsamples by LC-MS/MS after microQuEChERS extraction	2
Challenges of Implementing Ultrahigh-Throughput Mass Spectrometry in Absorption, Distribution, Metabolism and Excretion Bioanalysis	2
Feedback from the 10th European Bioanalysis Forum Young Scientist Symposium and from the Science Café discussions on sustainability in bioanalysis	2
Nitrogen blowing DµSPE of sunitinib, imatinib, and dasatinib using LDH/MIL-101(Cr)-NO 2 composite prior to HPLC-PDA	2
Development, validation and application of a liquid chromatography–tandem mass spectrometry method for quantifying lurasidone in dried blood spot samples	2
Validated GC-MS methods to detect ethylene, diethylene, and triethylene glycol in serum, plasma, and urine samples	2
Signature Peptide Selection Workflow for Biomarker Quantification Using LC–MS-Based Targeted Proteomics	2
Recommendations on qPCR/ddPCR Assay Validation by GCC	2
Assessment of mirvetuximab soravtansine immunogenicity in patients with folate receptor alpha-positive ovarian cancer	2
The GSK Bioanalytical Hub Model in Bioanalysis: Maximizing the Synergies of Co-Locating Various Platforms in Support of Regulated and Nonregulated Study end Points	2
Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug development	2
Immunogenicity assay supporting clinical development of RGB-19, a proposed biosimilar to RoActemra®	2
Development and validation of an ultra-sensitive UPLC-MS/MS method for quantification of monomethyl auristatin E in cynomolgus monkey plasma: application to pharmacokinetic study	2
The use of surrogate matrices in bioanalytical preclinical safety testing using chromatographic methods: a recommendation from the European Bioanalysis forum	2
Evaluation of singlicate vs duplicate analysis in ligand binding assays: a case study with IFN-γ in mouse and NHP models	2
Regulatory and scientific considerations in PK and biomarker assay validation: lessons from bioanalytical practice	2